Terms: = Endocrine gland cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
13 results:
1. Molecular tools for diagnosing diseases of the adrenal cortex.
Faucz FR; Maria AG; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2023 Jun; 30(3):154-160. PubMed ID: 37067987
[TBL] [Abstract] [Full Text] [Related]
2. Strategies Towards Improving clinical outcomes of Peptide Receptor Radionuclide Therapy.
Minczeles NS; Hofland J; de Herder WW; Brabander T
Curr Oncol Rep; 2021 Mar; 23(4):46. PubMed ID: 33721105
[TBL] [Abstract] [Full Text] [Related]
3. Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma.
Cartwright S; Fingeret A
Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):351-357. PubMed ID: 32701516
[TBL] [Abstract] [Full Text] [Related]
4. Malignant pheochromocytoma and paraganglioma: management options.
Corssmit EPM; Snel M; Kapiteijn E
Curr Opin Oncol; 2020 Jan; 32(1):20-26. PubMed ID: 31599769
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Alterations in Sporadic Pituitary Tumors.
Bi WL; Larsen AG; Dunn IF
Curr Neurol Neurosci Rep; 2018 Feb; 18(1):4. PubMed ID: 29396598
[TBL] [Abstract] [Full Text] [Related]
6. An update on noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Range DE; Jiang XS
Curr Opin Oncol; 2018 Jan; 30(1):1-7. PubMed ID: 29049050
[TBL] [Abstract] [Full Text] [Related]
7. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract] [Full Text] [Related]
8. Long-term follow-up of patients with differentiated thyroid cancer who had negative 131I whole-body scan at first evaluation after treatment.
Caminha LS; Momesso DP; Vaisman F; Corbo R; Vaisman M
Clin Nucl Med; 2013 Oct; 38(10):765-9. PubMed ID: 23917784
[TBL] [Abstract] [Full Text] [Related]
9. Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer.
Ino K
Curr Opin Obstet Gynecol; 2011 Feb; 23(1):13-8. PubMed ID: 20930628
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas.
Filopanti M; Lania AG; Spada A
Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):43-53. PubMed ID: 19929252
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years' experience in the Kinki District of Japan (1990-2006).
Kokawa K; Mikami Y; Sakata H; Oki N; Tanakas T; Yamazaki M; Nakata Y; Umesaki N
Eur J Gynaecol Oncol; 2009; 30(2):155-61. PubMed ID: 19480244
[TBL] [Abstract] [Full Text] [Related]
12. Predictors of outcome in patients with papillary thyroid carcinoma.
Kjellman P; Zedenius J; Lundell G; Bäckdahl M; Farnebo LO; Hamberger B; Larsson C; Wallin G
Eur J Surg Oncol; 2006 Apr; 32(3):345-52. PubMed ID: 16459050
[TBL] [Abstract] [Full Text] [Related]
13. [Results of bilateral surgical technique in primary hyperparathyroidism].
Walgenbach S; Junginger T
Zentralbl Chir; 2001 Apr; 126(4):254-60. PubMed ID: 11370385
[TBL] [Abstract] [Full Text] [Related]